ZVRA
Zevra Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$595.29M
P/E Ratio
7.46
EPS
$1.35
Beta
0.89
52W High
$13.16
52W Low
$7.16
50-Day MA
$9.61
200-Day MA
$9.46
Dividend Yield
—
Profit Margin
78.20%
Forward P/E
22.57
PEG Ratio
10.67
About Zevra Therapeutics Inc.
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
Fundamentals
| Revenue (TTM) | $106.47M |
| Gross Profit (TTM) | $89.99M |
| EBITDA | -179,000 |
| Operating Margin | 27.30% |
| Return on Equity | 85.70% |
| Return on Assets | -1.14% |
| Revenue/Share (TTM) | $1.93 |
| Book Value | $2.72 |
| Price-to-Book | 3.88 |
| Price-to-Sales (TTM) | 5.59 |
| EV/Revenue | 4.441 |
| EV/EBITDA | 4.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 183.40% |
| Shares Outstanding | $59.12M |
| Float | $54.58M |
| % Insiders | 1.41% |
| % Institutions | 66.94% |
Historical Volatility
HV 10-Day
45.66%
HV 20-Day
41.42%
HV 30-Day
43.65%
HV 60-Day
56.91%
HV Rank
25.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($22.78 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/2/2026